Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro

Detalhes bibliográficos
Autor(a) principal: Jacinto, Telma Maria Andrade
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/10160
Resumo: Cancer is one of the leading causes of death in the worldwide population and recent data indicates that its incidence will continue to increase in the next years. On the other hand, the traditional treatments such as surgery, radiotherapy, and chemotherapy have low therapeutic efficacies and induce systemic toxicity. Such have prompted the development of new therapeutic approaches for cancer. In this area, the application of nanomaterials to mediate a photothermal effect (i.e. heat generation upon light irradiation) and consequently induce the death of cancer cells has gained a considerable recognition by researchers and health professionals. Among the various types of nanoparticles developed until now, gold coremesoporous silica coated nanoparticles (AuMSS) have excellent physicochemical and biological properties, which allow their application as photothermal agents and drug carriers. However, the application of these nanoparticles in cancer therapy is hindered by their reduced blood circulation time and poor specificity to the tumor tissue. Thus, the present dissertation aimed to develop a new surface functionalization for the rodshaped AuMSS nanoparticles based on biofunctional polymers, in order to increase its blood circulation time, internalization by the cancer cells, and ultimately increase the therapeutic effect. For this purpose, the rod-shaped AuMSS were chemically modified with different ratios (1:1 and 4:1) of D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS) and Hyaluronic Acid (HA). HA was selected due to its specificity towards the CD44 receptors that are overexpressed in the cancer cells’ membrane. On the other hand, TPGS owing to its amphiphilic nature is able to increase the nanomaterials solubility, and consequently its colloidal stability that enhances the blood circulation time. The obtained results showed that the rod-shaped AuMSS’ functionalization neutralized the nanoparticles’ surface charge, from -28 ± 10 mV to -3 ± 5 mV and 11 ± 2 mV for AuMSS-TPGSHA (1:1) and (4:1), respectively, without compromising the nanomaterials’ size distribution or photothermal capacity. Moreover, the success of the polymers grafting to the nanoparticles was confirmed by Fourier Transform Infrared (FTIR) spectroscopy and thermogravimetric analysis (TGA). In vitro assays demonstrated the biocompatibility of all formulations at concentrations up to 200 µg / mL in both healthy (fibroblast) and cancerous (cervical cancer) cells. However, the functionalization with TPGS and HA has improved the nanomaterials’ hemocompatibility as well as their selectivity towards cervical cancer cells. Finally, the photothermal effect mediated by the rod-shaped AuMSS effectively induced the death of the cancer cells In summary, the results presented in this dissertation confirm the successful functionalization of the AuMSS with the TPGS and HA. Additionally, the AuMSSs’ potential to be applied in cancer photothermal therapy was also demonstrated.
id RCAP_2fe2ee364eedce14505c77d9131f3253
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/10160
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do CancroCancroHaNanopartículas de Ouro Com Revestimento de SílicaTerapia FototérmicaTpgsDomínio/Área Científica::Ciências Naturais::Ciências QuímicasCancer is one of the leading causes of death in the worldwide population and recent data indicates that its incidence will continue to increase in the next years. On the other hand, the traditional treatments such as surgery, radiotherapy, and chemotherapy have low therapeutic efficacies and induce systemic toxicity. Such have prompted the development of new therapeutic approaches for cancer. In this area, the application of nanomaterials to mediate a photothermal effect (i.e. heat generation upon light irradiation) and consequently induce the death of cancer cells has gained a considerable recognition by researchers and health professionals. Among the various types of nanoparticles developed until now, gold coremesoporous silica coated nanoparticles (AuMSS) have excellent physicochemical and biological properties, which allow their application as photothermal agents and drug carriers. However, the application of these nanoparticles in cancer therapy is hindered by their reduced blood circulation time and poor specificity to the tumor tissue. Thus, the present dissertation aimed to develop a new surface functionalization for the rodshaped AuMSS nanoparticles based on biofunctional polymers, in order to increase its blood circulation time, internalization by the cancer cells, and ultimately increase the therapeutic effect. For this purpose, the rod-shaped AuMSS were chemically modified with different ratios (1:1 and 4:1) of D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS) and Hyaluronic Acid (HA). HA was selected due to its specificity towards the CD44 receptors that are overexpressed in the cancer cells’ membrane. On the other hand, TPGS owing to its amphiphilic nature is able to increase the nanomaterials solubility, and consequently its colloidal stability that enhances the blood circulation time. The obtained results showed that the rod-shaped AuMSS’ functionalization neutralized the nanoparticles’ surface charge, from -28 ± 10 mV to -3 ± 5 mV and 11 ± 2 mV for AuMSS-TPGSHA (1:1) and (4:1), respectively, without compromising the nanomaterials’ size distribution or photothermal capacity. Moreover, the success of the polymers grafting to the nanoparticles was confirmed by Fourier Transform Infrared (FTIR) spectroscopy and thermogravimetric analysis (TGA). In vitro assays demonstrated the biocompatibility of all formulations at concentrations up to 200 µg / mL in both healthy (fibroblast) and cancerous (cervical cancer) cells. However, the functionalization with TPGS and HA has improved the nanomaterials’ hemocompatibility as well as their selectivity towards cervical cancer cells. Finally, the photothermal effect mediated by the rod-shaped AuMSS effectively induced the death of the cancer cells In summary, the results presented in this dissertation confirm the successful functionalization of the AuMSS with the TPGS and HA. Additionally, the AuMSSs’ potential to be applied in cancer photothermal therapy was also demonstrated.O cancro é uma das principais causas de morte a nível mundial, e dados recentes apontam para um aumento na incidência desta doença nos próximos anos. Por outro lado, os tratamentos convencionais tais como a cirurgia, radioterapia e quimioterapia apresentam uma baixa eficácia e toxicidade sistémica, o que tem motivado o desenvolvimento de novas terapias anticancerígenas. Nesta área, a aplicação de nanomateriais para mediar um efeito fototérmico (i.e. produção de calor em resposta a um estímulo de luz) e consequente morte das células cancerígenas tem sido alvo de diferentes estudos realizados por parte dos investigadores e profissionais de saúde. Entre os diversos tipos de nanopartículas desenvolvidas até ao momento, as nanopartículas de ouro revestidas com sílica mesoporosa (AuMSS) apresentam excelentes propriedades físico-químicas e biológicas, que possibilitam a sua aplicação como agentes fototérmicos e transportadores de fármacos. Contudo, a aplicação destas nanopartículas na terapia contra o cancro é dificultada pelo seu reduzido tempo de circulação na corrente sanguínea e baixa especificidade para o tecido tumoral. As limitações destes sistemas despoletaram o desenvolvimento da presente dissertação que teve como objetivo a funcionalização de superfície das nanopartículas AuMSS com forma de bastonete com novos polímeros biofuncionais com a finalidade de aumentar o seu tempo de circulação na corrente sanguínea, a sua internalização pelas células cancerígenas, e ainda incrementar o seu efeito terapêutico. Para tal, as AuMSS em forma de bastonete foram modificadas quimicamente com diferentes rácios (1:1 e 4:1) de Succinato de D-a-tocoferol polietilenoglicol 1000 (TPGS) e Ácido Hialurónico (HA). O HA foi selecionado devido à sua especificidade para os recetores CD44 que estão sobreexpressos na membrana das células cancerígenas. Por outro lado, o TPGS devido à sua natureza anfifílica possuiu a capacidade de aumentar a solubilidade, e por consequência a estabilidade coloidal das nanopartículas, incrementando assim o seu tempo de circulação no sangue. Os resultados obtidos demonstraram que a funcionalização dos AuMSS em forma de bastonete permitiu a neutralização da carga de superfície de -28 ± 10 mV para -3 ± 5 mV e 11 ± 2 mV, para as AuMSS-TPGS-HA (1:1) e (4:1), respetivamente, sem comprometer a distribuição de tamanhos dos nanomateriais ou a sua capacidade fototérmica. Para além disto, o sucesso da ligação dos polímeros às nanopartículas foi confirmado por espectroscopia de infravermelho por transformada de Fourier (FTIR) e análise termogravimétrica (TGA). Nos ensaios in vitro foi demonstrada a biocompatibilidade de todas as formulações produzidas até concentrações de 200 µg/mL, quando estas foram colocadas em contacto com células saudáveis (fibroblastos) e cancerígenas (cancro do colo do útero). Contudo, a funcionalização com TPGS e HA melhorou a hemocompatibilidade dos nanomateriais bem como a sua seletividade para as células cancerígenas do colo do útero. Por fim, o efeito fototérmico mediado pelas AuMSS com forma de bastonete induziu eficazmente a morte das células cancerígenas. Em suma, os resultados apresentados nesta dissertação confirmam que a funcionalização das AuMSS com os polímeros TPGS e HA foi bem-sucedida. Por outro lado, foi também demonstrado o potencial das AuMSS para serem aplicadas na terapia fototérmica do cancro.Correia, Ilídio Joaquim SobreiraMoreira, André FerreiraRodrigues, Ana Carolina FélixuBibliorumJacinto, Telma Maria Andrade2022-06-23T00:30:17Z2019-07-152019-06-242019-07-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/10160TID:202349012enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:51:35Zoai:ubibliorum.ubi.pt:10400.6/10160Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:50:11.453609Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
title Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
spellingShingle Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
Jacinto, Telma Maria Andrade
Cancro
Ha
Nanopartículas de Ouro Com Revestimento de Sílica
Terapia Fototérmica
Tpgs
Domínio/Área Científica::Ciências Naturais::Ciências Químicas
title_short Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
title_full Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
title_fullStr Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
title_full_unstemmed Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
title_sort Desenvolvimento e Funcionalização de Nanopartículas de Ouro com Revestimento de Sílica para Aplicação na Terapia do Cancro
author Jacinto, Telma Maria Andrade
author_facet Jacinto, Telma Maria Andrade
author_role author
dc.contributor.none.fl_str_mv Correia, Ilídio Joaquim Sobreira
Moreira, André Ferreira
Rodrigues, Ana Carolina Félix
uBibliorum
dc.contributor.author.fl_str_mv Jacinto, Telma Maria Andrade
dc.subject.por.fl_str_mv Cancro
Ha
Nanopartículas de Ouro Com Revestimento de Sílica
Terapia Fototérmica
Tpgs
Domínio/Área Científica::Ciências Naturais::Ciências Químicas
topic Cancro
Ha
Nanopartículas de Ouro Com Revestimento de Sílica
Terapia Fototérmica
Tpgs
Domínio/Área Científica::Ciências Naturais::Ciências Químicas
description Cancer is one of the leading causes of death in the worldwide population and recent data indicates that its incidence will continue to increase in the next years. On the other hand, the traditional treatments such as surgery, radiotherapy, and chemotherapy have low therapeutic efficacies and induce systemic toxicity. Such have prompted the development of new therapeutic approaches for cancer. In this area, the application of nanomaterials to mediate a photothermal effect (i.e. heat generation upon light irradiation) and consequently induce the death of cancer cells has gained a considerable recognition by researchers and health professionals. Among the various types of nanoparticles developed until now, gold coremesoporous silica coated nanoparticles (AuMSS) have excellent physicochemical and biological properties, which allow their application as photothermal agents and drug carriers. However, the application of these nanoparticles in cancer therapy is hindered by their reduced blood circulation time and poor specificity to the tumor tissue. Thus, the present dissertation aimed to develop a new surface functionalization for the rodshaped AuMSS nanoparticles based on biofunctional polymers, in order to increase its blood circulation time, internalization by the cancer cells, and ultimately increase the therapeutic effect. For this purpose, the rod-shaped AuMSS were chemically modified with different ratios (1:1 and 4:1) of D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS) and Hyaluronic Acid (HA). HA was selected due to its specificity towards the CD44 receptors that are overexpressed in the cancer cells’ membrane. On the other hand, TPGS owing to its amphiphilic nature is able to increase the nanomaterials solubility, and consequently its colloidal stability that enhances the blood circulation time. The obtained results showed that the rod-shaped AuMSS’ functionalization neutralized the nanoparticles’ surface charge, from -28 ± 10 mV to -3 ± 5 mV and 11 ± 2 mV for AuMSS-TPGSHA (1:1) and (4:1), respectively, without compromising the nanomaterials’ size distribution or photothermal capacity. Moreover, the success of the polymers grafting to the nanoparticles was confirmed by Fourier Transform Infrared (FTIR) spectroscopy and thermogravimetric analysis (TGA). In vitro assays demonstrated the biocompatibility of all formulations at concentrations up to 200 µg / mL in both healthy (fibroblast) and cancerous (cervical cancer) cells. However, the functionalization with TPGS and HA has improved the nanomaterials’ hemocompatibility as well as their selectivity towards cervical cancer cells. Finally, the photothermal effect mediated by the rod-shaped AuMSS effectively induced the death of the cancer cells In summary, the results presented in this dissertation confirm the successful functionalization of the AuMSS with the TPGS and HA. Additionally, the AuMSSs’ potential to be applied in cancer photothermal therapy was also demonstrated.
publishDate 2019
dc.date.none.fl_str_mv 2019-07-15
2019-06-24
2019-07-15T00:00:00Z
2022-06-23T00:30:17Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/10160
TID:202349012
url http://hdl.handle.net/10400.6/10160
identifier_str_mv TID:202349012
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136392127709184